These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27694876)

  • 1. Editorial: Intravenous Proton Pump Inhibitors for Bleeding Peptic Ulcer: What is the Most Cost-Effective Approach?
    Peterson K; Bjorkman DJ
    Am J Gastroenterol; 2016 Oct; 111(10):1399-1401. PubMed ID: 27694876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing intravenous and oral proton pump inhibitor therapy for bleeding peptic ulcers following endoscopic management: a systematic review and meta-analysis.
    Tringali A; Manta R; Sica M; Bassotti G; Marmo R; Mutignani M
    Br J Clin Pharmacol; 2017 Aug; 83(8):1619-1635. PubMed ID: 28181291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the era of intravenous proton pump inhibitors coming to an end in patients with bleeding peptic ulcers? Meta-analysis of the published literature.
    Jian Z; Li H; Race NS; Ma T; Jin H; Yin Z
    Br J Clin Pharmacol; 2016 Sep; 82(3):880-9. PubMed ID: 26679691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of High Dose and Standard Dose Proton Pump Inhibitor before Endoscopy in Patients with Non-Portal Hypertension Bleeding.
    Rattanasupar A; Sengmanee S
    J Med Assoc Thai; 2016 Sep; 99(9):988-95. PubMed ID: 29927201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis: comparison of oral vs. intravenous proton pump inhibitors in patients with peptic ulcer bleeding.
    Tsoi KK; Hirai HW; Sung JJ
    Aliment Pharmacol Ther; 2013 Oct; 38(7):721-8. PubMed ID: 23915096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding.
    Enns RA; Gagnon YM; Rioux KP; Levy AR
    Aliment Pharmacol Ther; 2003 Jan; 17(2):225-33. PubMed ID: 12534407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries.
    Mo C; Sun G; Lu ML; Zhang L; Wang YZ; Sun X; Yang YS
    World J Gastroenterol; 2015 May; 21(17):5382-92. PubMed ID: 25954113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study.
    Tseng GY; Fang CT; Lin HJ; Yang HB; Tseng GC; Wang PC; Liao PC; Cheng YT; Huang CH
    Aliment Pharmacol Ther; 2009 Aug; 30(4):406-13. PubMed ID: 19485981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy.
    Sung JJ; Suen BY; Wu JC; Lau JY; Ching JY; Lee VW; Chiu PW; Tsoi KK; Chan FK
    Am J Gastroenterol; 2014 Jul; 109(7):1005-10. PubMed ID: 24777150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
    Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing or Dosing of Intravenous Proton Pump Inhibitors in Acute Upper Gastrointestinal Bleeding Has Low Impact on Costs.
    Lu Y; Adam V; Teich V; Barkun A
    Am J Gastroenterol; 2016 Oct; 111(10):1389-1398. PubMed ID: 27140030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the best strategy for diagnosis and treatment of Helicobacter pylori in the prevention of recurrent peptic ulcer bleeding? A cost-effectiveness analysis.
    Gené E; Sanchez-Delgado J; Calvet X; Gisbert JP; Azagra R
    Value Health; 2009; 12(5):759-62. PubMed ID: 19490560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding.
    Mesihovic R; Vanis N; Mehmedovic A; Gornjakovic S; Gribajcevic M
    Med Arh; 2009; 63(6):323-7. PubMed ID: 20380111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis.
    Barkun AN; Herba K; Adam V; Kennedy W; Fallone CA; Bardou M
    Aliment Pharmacol Ther; 2004 Mar; 19(5):591-600. PubMed ID: 14987328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of proton pump inhibitor therapy for acute peptic ulcer-related bleeding.
    Erstad BL
    Crit Care Med; 2004 Jun; 32(6):1277-83. PubMed ID: 15187506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
    Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
    Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.
    Liu N; Liu L; Zhang H; Gyawali PC; Zhang D; Yao L; Yang Y; Wu K; Ding J; Fan D
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1473-9. PubMed ID: 22646140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.
    Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A
    Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists.
    Barkun AN; Adam V; Martel M; Bardou M
    Value Health; 2013; 16(1):14-22. PubMed ID: 23337211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of acid-suppression therapy for treatment of non-variceal upper gastrointestinal bleeding.
    Olsen KM
    Am J Health Syst Pharm; 2005 May; 62(10 Suppl 2):S18-23. PubMed ID: 15905596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.